Evaluating a Physical Activity Index for Assessment and Counseling for Breast and Colon Cancer Survivors

NCT06340503 | Active Not Recruiting

• 3 other identifiers: IRB00111331WFBCCC 01123P30CA012197
• Study Type: interventional
• Target: 20
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this research study is to determine whether using the physical activity index screener, exercise coaching, and self-monitoring will increase physical activity and reduce time spent sitting or being inactive in patients who had breast or colon cancer.

Conditions

Breast Cancer; Colon Cancer

Keywords

Physical activity; Exercise coaching

Outcome Measures

Primary Outcomes (3)

• Number of Eligible Participants - Participation Rate

  Participation will be measured by the number of eligible participants who agree to participate. Investigators will calculate 95% confidence interval for each of the feasibility measures to determine the range of estimates that are consistent with the data.

  17 months

• Percentage of Participants to Complete Exercise Sessions - Adherence

  Adherence will be measured by the percent of participants who complete at least 3 out 5 exercise sessions. Investigators will calculate 95% confidence interval for each of the feasibility measures to determine the range of estimates that are consistent with the data.

  17 months

• Number of Participants Who Complete Study Questionnaires - Retention

  Retention will be defined as the number of participants who complete study questionnaires at baseline and one follow-up timepoint. Investigators will calculate 95% confidence interval for each of the feasibility measures to determine the range of estimates that are consistent with the data.

  At baseline and up to 17 months

Study Arms (2)

Exercise Group

EXPERIMENTAL

Participants randomized into the exercise group will receive a pre-exercise screening call about two weeks after enrolling into the study and complete the six (6) study visits and pre-determined test and procedures for the patient intervention arm.

Device: Research-grade accelerometer; Other: National Comprehensive Cancer Network (NCCN) Education Materials; Device: Garmin Vivofit activity tracker; Other: Exercise Consultation Calls; Other: Interview; Other: Physical Activity Index Assessment (Intervention Arm); Other: Health Surveys

Delayed Exercise Group

ACTIVE COMPARATOR

Participants randomized to the delayed exercise group, will have vitals collected and complete surveys at the first (baseline), 3-month, and 6-month visits pre-determined test and procedures for the waitlist control arm. The pre-exercise consultation will begin after the 6-month visit.

Device: Research-grade accelerometer; Other: National Comprehensive Cancer Network (NCCN) Education Materials; Device: Garmin Vivofit activity tracker; Other: Interview; Other: Physical Activity Index Assessment (Control Arm); Other: Health Surveys

Interventions

Research-grade accelerometer DEVICE

Participants will be instructed to wear device for 7 days prior to each visit and to bring the device to each visit. Study staff will extract data from the device within 14 days after each appointment and return the device to patients by mail.

Delayed Exercise Group; Exercise Group

National Comprehensive Cancer Network (NCCN) Education Materials OTHER

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) are comprised of recommendations for the prevention, diagnosis, and management of malignancies across the continuum of care.

Delayed Exercise Group; Exercise Group

Garmin Vivofit activity tracker DEVICE

This device can automatically capture and classify different physical activities such as walking, running, biking, swimming and using an elliptical.

Delayed Exercise Group; Exercise Group

Exercise Consultation Calls OTHER

The intervention group will receive five monthly exercise consultation calls with an exercise coach in between clinical visits and be provided with an exercise log for their personal use

Exercise Group

Interview OTHER

The interviews will be conducted by a trained Q-PRO interviewer and audio recorded. Interviews are expected to last approximately 30 minutes. Discussion will include acceptability of the PAI intervention, related tools, and clinical experiences and will help shape/inform refinements need for a larger efficacy trial

Delayed Exercise Group; Exercise Group

Physical Activity Index Assessment (Intervention Arm) OTHER

Assessment will capture frequency and time spent in strenuous, moderate, and mild PA over the past 7 days. Survivors also report hours of TV or similar sedentary screen time per week as a measure of sedentary behavior. Completed at months 1, 3, 6, 9 and 12 while on study

Exercise Group

Physical Activity Index Assessment (Control Arm) OTHER

Assessment will capture frequency and time spent in strenuous, moderate, and mild PA over the past 7 days. Survivors also report hours of TV or similar sedentary screen time per week as a measure of sedentary behavior. Completed at months 6, 9 and 12 while on study.

Delayed Exercise Group

Health Surveys OTHER

Various health surveys will be completed to assess participant health and physical activities.

Delayed Exercise Group; Exercise Group

Eligibility Criteria

• Age: 50 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Survivors of breast or colon cancer (stages 0-III) diagnosed within the last three years prior to enrollment.
• Completed primary treatment (surgery, chemotherapy, and/or radiation) at least 3 months prior to enrollment.
• At least 50 years of age or older.
• Access to internet or cellular plan for video calls.
• Being willing and able to comply with the approved protocol and able to sign an IRB-approved informed consent document directly, remotely or via electronic consent.
• Able to read and speak English

You may not qualify if:

• Participants with metastatic disease.
• Participants with recurrence or diagnosis of a different cancer.
• Participants receiving treatment other than maintenance therapy for their primary cancer (breast or colon).
• Participants has prior conditions that contraindicate exercise as determined by treating physician.
• Participants has gross cognitive impairment as determined by treating physician.

Sponsors & Collaborators

• National Cancer Institute (NCI): collaborator
• Wake Forest University Health Sciences: lead

Study Sites (1)

Atrium Health Wake Forest Baptist Comprehensive Cancer Center

Winston-Salem, North Carolina, 27157, United States

Location

MeSH Terms

Conditions

Breast Neoplasms; Colonic Neoplasms; Motor Activity

Interventions

Interviews as Topic; Health Surveys

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases; Colorectal Neoplasms; Intestinal Neoplasms; Gastrointestinal Neoplasms; Digestive System Neoplasms; Digestive System Diseases; Gastrointestinal Diseases; Colonic Diseases; Intestinal Diseases; Behavior

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health; Surveys and Questionnaires

Study Officials

• Shirley Bluethmann

  Wake Forest Baptist Comprehensive Cancer Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 25, 2024
• First Posted: April 1, 2024
• Study Start: November 6, 2024
• Primary Completion (Estimated): June 1, 2026
• Study Completion (Estimated): June 1, 2026
• Last Updated: March 19, 2026

Record last verified: 2026-03

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)